Physician profile
Itha Dalrymple
NPI 1356758833
$888.05
in general payments reported to CMS, 2019-2025
20 companies · $26.17 in 2025
The $26.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2021: $271 · 2022: $220 · 2023: $119 · 2025: $26.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.75 | 2021-2023 | Ubrelvy |
| Novo Nordisk INC | $94.06 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.30 | 2019 | |
| Intuitive Surgical, INC. | $61.69 | 2023 | Da Vinci Surgical System |
| Pfizer INC. | $51.73 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $47.28 | 2019-2021 | |
| Abbott Laboratories | $37.59 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $35.57 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $33.36 | 2022 | |
| Amgen INC. | $30.50 | 2021-2022 | |
| Boston Scientific Corporation | $26.17 | 2025 | General - Pain Management |
| Novartis Pharmaceuticals Corporation | $23.81 | 2022 | |
| Dexcom, INC. | $20.39 | 2021 | |
| Baxter Healthcare | $17.52 | 2023 | Hillrom - Retinavue 700 Imager |
| Shield Therapeutics INC | $17.07 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $16.82 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.08 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.07 | 2022 | |
| Coala Life INC | $12.77 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itha Dalrymple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.